Gergley is an expert in the preparation and execution of commercial strategy in Rare Disease. He has developed go-to-market strategy (commercial model, sales strategy, financial plan, target market identification, competitive landscape analysis, trends and dynamics, comprehensive cross functional launch planning and launch metrics development) for large pharma. He is skilled at managing therapeutic assets with stakeholders across the globe where he facilitates transparent communication between patient organizations, policymakers, and health practitioners. In his spare time he likes to sail his boat and spend time with his family.